News
It will grow to $9.02 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, July 3, 2025 /EINPresswire.com/ -- Save ...
Paraphase – a computational tool that accurately resolves and analyzes paralogous genes – unlocks the difficult-to-analyze ...
Many SMA patients continue to see gains in motor function with long-term Spinraza treatment, a real-world study from ...
Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 ...
In perhaps a first in the country, a newborn found carrying the SMN1 gene mutation for Spinal Muscular Atrophy (SMA) through prenatal genetic screening is being administered presymptomatic ...
It is thought that salbutamol increases production of SMN from the SMN2 gene. Normally, SMN2 produces only about 10% as much functional SMN protein as the SMN1 gene due to a slight difference in the ...
One of the most commonly used techniques for genotyping of single-nucleotide polymorphism (SNP) is detection of single-base extensions (SBEs). We present a new, rapid, simple, and highly reliable ...
Session ID: 2025-07-05:9a280840deb0acb14c589c11 Player Element ID: vjs_video_3 ...
Small molecule, peptide, and protein-based drugs have been developed over decades to treat various diseases. The importance of gene therapy as an alternative to traditional drugs has increased after ...
5q-Spinal muscular atrophy (SMA) is a progressive, autosomal recessive neuromuscular disease with an incidence of 1 in 14,848 births.1 SMA is characterised by proximal muscle weakness and in severe ...
Alsheebani's care team at The James, led by Dr. Marcos de Lima and Dr. Roberta Azbell, employed gene therapy to treat Alsheebani's illness by injecting him with a medication that allows stem cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results